Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. [electronic resource]
Producer: 19920720Description: 24-30 p. digitalISSN:- 0735-1097
- Acute Disease
- Adult
- Aged
- Cause of Death
- Confidence Intervals
- Drug Administration Schedule
- Female
- Humans
- Male
- Middle Aged
- Pulmonary Embolism -- blood
- Radiography
- Recombinant Proteins -- therapeutic use
- Thrombolytic Therapy -- adverse effects
- Tissue Plasminogen Activator -- therapeutic use
- Urokinase-Type Plasminogen Activator -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.